By Alan M. Kirschenbaum –
Just ahead of a predicted snow storm in the Baltimore-Washington area, CMS yesterday issued a blizzard of 658 pages constituting its final regulation implementing changes to the Medicaid Drug Rebate Program. Although this is a final rule, CMS will be accepting comments on certain provisions relating to the alternative rebate for line extension drugs.
Hyman, Phelps & McNamara, P.C. will be preparing a memo summarizing the rule in the near future. We’ll also be conducting a webinar on the rule in collaboration with KPMG’s government pricing group. The date and other details will be announced on this blog over the next few days.